Información del artículo
Resumen
En este artículo de revisión se exponen una serie de recomendaciones para efectuar el ajuste de la dosis de los medicamentos más utilizados en la clínica, haciendo una mención especial a los que se usan en reumatología. Se comentan también las limitaciones de las fórmulas más empleadas para estimar el funcionalismo renal.
Palabras clave:
Ajuste de la dosis
Enfermedad renal crónica
Insuficiencia renal
Abstract
The present article reviews a series of recommendations on dose adjustment of the drugs most widely used in clinical practice, especially those used in rheumatology. The limitations of the equations most frequently employed to estimate renal function are also discussed.
Keywords:
Dose adjustment
Chronic renal disease
Renal insufficiency
El Texto completo está disponible en PDF
Bibliografía
[1.]
G.M. Chertow, J. Lee, G.J. Kuperman, et al.
Guided medication dosing for inpartients with renal insufficiency.
JAMA, 286 (2001), pp. 2839-2844
[2.]
L. Salomon, G. Deray, M.C. Jaudon, et al.
Medication misuse in hospitalized patients with renal impairment.
Int Soc Qual Health Care, 15 (2003), pp. 331-335
[3.]
C.L. Long, M.A. Raebel, D.W. Price, D.J. Magid.
Compliance with dosing guidelines in patients with chronic kidney disease.
Ann Pharmacother, 38 (2004), pp. 853-858
[4.]
P.E. Marik, L. Fromm.
A case series of hospitalized patients with elevated digoxin levels.
Am J Med, 105 (1998), pp. 110-115
[6.]
L. Vidal, M. Shavit, A. Fraser, M. Paul, L. Leibovici.
Systematic comparison of four sources of drug information regarding adjustement of dose for renal function.
BMJ, 331 (2005), pp. 263-266
[7.]
J. Kappel, P. Calissi.
Nephrology: 3. Safe drug prescribing for patients with renal insufficiency.
CMAJ, 166 (2002), pp. 473-477
[8.]
J. Coresh, B.C. Astor, G. McQuillan, et al.
Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate.
Am J Kidney Dis, 39 (2002), pp. 920-929
[9.]
A.S. Levey, J.P. Bosch, J.B. Lewis, et al.
A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.
Ann Intern Med, 130 (1999), pp. 461-470
[10.]
S. Gracia, R. Montenes, J. Bover, et al.
Documento de consenso: Recomendaciones sobre la utilizacion de ecuaciones para la estimacion del filtrado glomerular en adultos.
Nefrologia, 26 (2006), pp. 658-665
[11.]
L.A. Stevens, J. Coresh, T. Greene, A.S. Levey.
Assessing kidney function – Measured and estimated glomerular filtration rate.
N Engl J Med, 354 (2006), pp. 2473-2483
[12.]
Anònim.
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.
Am J Kidney Dis, 39 (2002), pp. S1-S266
[13.]
R. Faull, L. Lee.
Prescribing in renal disease.
Aust Prescr, 30 (2007), pp. 17-20
[14.]
M.Y. Munar, H. Singh.
Drug dosing adjustements in patients with chronic kidney disease.
Am Fam Physician, 75 (2007), pp. 1487-1496
[15.]
L. Niksic, P. Saudan, F. Boehlen.
Anticoagulation chez l’insuffisant rénal.
Rev Med Suisse, 2 (2006), pp. 586-592
[16.]
W. Lim, F. Dentali, J.W. Eikelboom, M.A. Crowther.
Meta-analysis:Low-molecularweight heparin and bleeding in patients with severe renal insufficiency.
Ann Intern Med, 144 (2006), pp. 673-684
[17.]
S. Gabardi, S. Abramson.
Drug dosing in chronic kidney disease.
Med Clin North Am, 89 (2005), pp. 649-687
[18.]
A. Grand’Maison, A.F. Charest, W.H. Geerts.
Anticoagulant use in patients with chronic renal impairement.
Am J Cardiovasc Drugs, 5 (2005), pp. 291-305
[19.]
Micromedex 2002-2007 [citada Jun 2007]. Disponible en: http://www.thomsonhc.com/home/dispatch
[20.]
L.M. Cohen, E.G. Tessier, M.J. Germain, N.B. Levy.
Update on psychotropic medication use in renal disease.
Psychosomatics, 45 (2004), pp. 34-48
[21.]
Lauzurica R, Alcázar R, Martín G. Fármacos e insuficiencia renal. En: Sociedad Española de Nefrología, editor. Normas de actuación clínica en nefrología NAC. Barcelona: Hartcourt Brace; 1998. p. 173-85.
[22.]
L. Cousin, M. Le Berre, V. Launay, H. Izzedine, G. Deray.
Dosing guidelines for fluconazole in patients with renal failure.
Nephrol Dial Transplant, 18 (2003), pp. 2227-2231
[23.]
D.N. Gilbert, R.C. Moellering, G.E. Eliopoulos, M.A. Sande.
The Sanford guide to antimicrobial therapy.
36th ed., Antimicrobial Therapy, (2006),
[24.]
A. Swarup, N. Sachdeva, H.R. Schumacher.
Dosing of antirheumatic drugs in renal disease and dialysis.
J Clin Rheumatol, 10 (2004), pp. 190-204
[25.]
J.J. Montseny, A. Meyrier, R.K. Gherardi.
Cochicine toxicity in patients with renal failure.
Nephrol Dial Transplant, 11 (1996), pp. 2055-2058
[26.]
BC Cancer Agency 2008 [citada Ago 2008]. Disponible en: http://www.bccancer.bc.ca/HPI/DrugDatabase/DrugIndexPro/Cyclophosphamide.htm
[27.]
R. Rau, G. Herborn.
Benefit and risk of methotrexate treatment in rheumatoid arthritis.
Clin Exp Rheumatol, 22 (2004), pp. S83-94
[28.]
Royal Berkshire Guidelines 2008. [citada Ago 2008]. Disponible en: http://www.royalberkshire.nhs.uk/wards_departments/r/rheumatology_department/rheumatology_-_for_gps_and_ref.aspx?theme=patient
Copyright © 2009. Sociedad Española de Reumatología